Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes—A Meta-Analysis
- 1k Downloads
Historically, blue dyes, 99Tc or a combination of the two tracers have been used for sentinel lymph node (SLN) mapping in cervical and endometrial cancer patients. Indocyanine green (ICG), as a tracer, has been recently introduced in this setting. Our goal was to assess the differences in overall and bilateral detection rates as well as in false-negative rates among the different tracers.
The electronic databases PubMed, MEDLINE, and Scopus were searched in January 2016 by searching the terms “sentinel lymph node” and “dye” and “indocyanine green,” and “cervical cancer” or “endometrial cancer.” Series comparing different tracers injected intracervically and reporting the detection rate and/or SLN false-negative rate were selected.
Forty-five studies were retrieved. Six studies including 538 patients met selection criteria. Compared with blue dyes, ICG SLN mapping had higher overall (odds ratio [OR] 0.27; 95 % confidence interval [CI] 0.15–0.50; p < 0.0001) and bilateral detection rates (OR 0.27; 95 % CI 0.19–0.40; p < 0.00001). No differences were found between ICG and 99TC, although these results are based on data of a single series. No differences in overall and bilateral detection rates were found between ICG and the combination of blue dyes and 99TC. The pooled analysis of false-negative rates data showed no difference in false-negative rates between tracers.
In cervical and endometrial cancer, ICG SLN mapping seems to be equivalent to the combination of blue dyes and 99TC in terms of overall and bilateral detection rates. Its safety profile and ease of use may favor its employment respect to conventional tracers.
KeywordsSentinel Lymph Node Endometrial Cancer Sentinel Lymph Node Biopsy Sentinel Lymph Node Mapping Endometrial Cancer Patient
Conflict of interest
All authors declare no conflict of interest.
- 2.http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed 30 April 2016.
- 3.http://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed 30 April 2016.
- 11.Plante M, Touhami O, Trinh XB, Renaud MC, Sebastianelli A, Grondin K, Gregoire J. Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature. Gynecol Oncol. 2015;137:443–7.CrossRefPubMedGoogle Scholar
- 14.Kataoka F, Susumu N, Yamagami W, et al. The importance of para-aortic lymph nodes in sentinel lymph node mapping for endometrial cancer by using hysteroscopic radio-isotope tracer injection combined with subserosal dye injection: prospective study. Gynecol Oncol. doi: 10.1016/j.ygyno.2015.12.023.PubMedGoogle Scholar
- 17.Holloway RW, Bravo RA, Rakowski JA, James JA, Jeppson CN, Ingersoll SB, Ahmad S. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging. Gynecol Oncol. 2012;126:25–9.CrossRefPubMedGoogle Scholar
- 20.Cormier B, Rozenholc AT, Gotlieb W, Plante M4, Giede C5; Communities of Practice (CoP) Group of Society of Gynecologic Oncology of Canada (GOC). Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization of future research. Gynecol Oncol. 2015;138:478–85.CrossRefPubMedGoogle Scholar
- 23.Papadia A, Imboden S, Siegenthaler F, Gasparri ML, Mohr S, Lanz S, Mueller MD. Laparoscopic indocyanine green sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol. 2016:1–6Google Scholar
- 25.Papadia A, Imboden S, Fink A, Gasparri ML, Bolla D, Mueller MD. Accuracy of sentinel lymph node mapping after previous hysterectomy in patients with occult cervical cancer. Ann Surg Oncol. 2016:1–7Google Scholar